CA
NZ
UK
AU
IND
US
A Form 4 filed on August 26, 2026, disclosed that Robert M. Tichio, a director of Permian Resources Corp (NYSE:PR), disposed of a combined 7,200 shares of Class A Common Stock on August 24, 2026, through two gift transactions at $0 per share.
George P. Sakellaris, Chief Executive Officer and Director of Ameresco, Inc. (NASDAQ:AMRC), filed a Form 4 on August 26, 2026, disclosing open-market purchases of 10,000 shares of Class A Common Stock across three transactions on August 24 and August 25, 2026.
Warren B. Kanders, CEO, Chairman, and a 10% owner of Cadre Holdings, Inc. (NYSE:CDRE), filed a Form 4 on August 26, 2026, disclosing the sale of 200,000 shares of common stock through Kanders SAF, LLC across August 24 and August 25, 2026.
Director Joseph W. Sutton filed a Form 4 with the SEC on August 26, 2026, disclosing an open-market purchase of 9,700 shares of Ameresco, Inc. (NYSE:AMRC) Class A Common Stock on August 24, 2026.
A Form 4 filed with the SEC on August 26, 2026, discloses that Jennifer L. Miller, a director of Ameresco, Inc. (NYSE:AMRC), purchased 2,000 shares of Class A Common Stock on August 24, 2026.
Peter Kaiser, Chief Development Officer of Ocular Therapeutix, Inc. (NASDAQ:OCUL), filed a Form 4 on August 26, 2026, disclosing the sale of 3,035 shares of common stock on August 24, 2026, pursuant to a Rule 10b5-1 automatic sale instruction to satisfy tax withholding obligations.
Kevin Craig Kaiser, Executive Vice President and Chief Credit Officer of Plumas Bancorp, filed a statement of changes in beneficial ownership on August 26, 2026, reporting the sale of 1,200 shares of common stock on that same date.
Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc., filed a Form 4 on August 26, 2026, reporting the sale of 3,296 shares of common stock on August 24, 2026, pursuant to a Rule 10b5-1 automatic sale instruction to cover tax withholding obligations.
Sanjay Nayak, Chief Strategy Officer of Ocular Therapeutix, Inc. (NASDAQ:OCUL), filed a Form 4 on August 26, 2026, disclosing the sale of 1,897 shares of common stock on August 24, 2026, to cover tax withholding obligations tied to the vesting of restricted stock units.
Douglas N. Currault II, Executive Vice President and General Counsel of Freeport-McMoRan Inc, filed a Form 4 on August 26, 2026, reporting option exercises and an open-market sale of common stock transacted on August 25, 2026.
Please wait processing your request...